• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Chronic Disease

Mortality disparities recorded within Hispanic/Latino groups pre-pandemic

byGrace YinandKiera Liblik
June 10, 2024
in Chronic Disease, Public Health
Reading Time: 3 mins read
Masks for personal protection for SARS-CoV-2 infection
Share on FacebookShare on Twitter

1. In this cohort study, within the pre-pandemic period, persons of Puerto Rican and Cuban backgrounds were found to have significantly higher rates of mortality compared to those of South American backgrounds.

2. There were no significant differences in all-cause two-year mortality rates within Hispanic/Latino groups during the pandemic.

Evidence Rating Level: 2 (Good)

Study Rundown: Within the United States, there has been historical data showing that a variation in all-cause mortality exists within subgroups of those belonging to Hispanic/Latino groups, which has been hypothesized to differ by proxy measures of acculturation to the country. However, factors contributing to mortality rates within specific groups are complex and multifactorial. It is hypothesized that there are aspects of Hispanic/Latino culture, lifestyle factors, etc., which may alter mortality risk. This was a large prospective cohort study evaluating cumulative all-cause mortality and its possible causes where differences existed amongst Hispanic/Latino populations from four cities within the United States. Results of the study found that there did exist within-group variation in all-cause mortality in the 11 years before the coronavirus disease 2019 (COVID-19) pandemic, which was explained by lifestyle, chronic disease, and clinical factors. Subsequently, during the pandemic, the differences in all-cause mortality between South American and Central American-identifying Hispanic/Latino persons were not statistically significant. Although it’s challenging to directly extrapolate these findings to Hispanic/Latino populations beyond the pools from which participants were sampled, this study offers interesting insights into the heterogeneities within this population. Further, it offers greater insight into Hispanic/Latino culture and population characteristics that may affect overall mortality.

Click to read the study in AIM

In-Depth [prospective cohort study]: This prospective, multicenter cohort study evaluated cumulative all-cause mortality and its associated etiologies amongst persons belonging to Hispanic/Latino ethnicities within the United States with recruitment spanning 2008 to 2011. The primary outcome of interest was to describe all-cause mortality during the study’s inclusion period, with additional outcomes of interest including etiologies of differential mortality risks amongst various groups and chronic conditions. Adults self-identifying as Hispanic or Latino between the ages of 18 and 74 residing in the Bronx (New York), Chicago (Illinois), Miami (Florida), and San Diego (California) were invited to participate per a multistage probability sampling design. Overall, 16,415 participants were invited to participate, and 15,568 were included in the final analysis. The analysis found that the overall 11-year cumulative all-cause mortality risk after adjustment for age differed by ethnicity pre-pandemic. Specifically, persons of Puerto Rican (6.3%; 95% Confidence Interval [CI], 5.2%-7.5%) and Cuban backgrounds (5.9%; 95% CI, 5.1%-6.8%) were found to have significantly higher rates of age-adjusted all-cause mortality compared to patients of South American background (2.3%; 95% CI, 1.6%-3.4%). There were no significant differences in two-year cumulative all-cause mortality when adjusted by age and sex between persons of South American and Central American backgrounds during the pandemic. A key limitation of this study is the absence of comparator groups, such as non-Hispanic White populations, to offer direct comparisons in mortality risk. Overall, this was a large population-based cohort study, which strengthened the existing pool of literature’s understanding of the heterogeneities that contribute to all-cause mortality and the changes in in all-cause mortality before and for a duration within the pandemic for this population.

RELATED REPORTS

A lower threshold for referral to the emergency department for outpatient hyperkalemia may reduce mortality

Borderline-low hemoglobin levels linked to increased mortality

Chronic exposure to particulate matter is associated with increased cardiovascular risk

Image: PD

©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: chronic diseaseHispaniclatinomortalitypopulation healthpublic health
Previous Post

Asciminib demonstrates superior efficacy for the treatment of CML in comparison to imatinib and second-generation TKIs

Next Post

Neoadjuvant Nivolumab and Ipilimumab in Resectable Stage III Melanoma

RelatedReports

Emergency

A lower threshold for referral to the emergency department for outpatient hyperkalemia may reduce mortality

September 16, 2026
Cardiology

Borderline-low hemoglobin levels linked to increased mortality

September 14, 2026
Cardiology

Chronic exposure to particulate matter is associated with increased cardiovascular risk

September 10, 2026
Rivaroxaban likely reduces risk of recurrent stroke in specific subgroup of patients with embolic stroke of undetermined source
Cardiology

The mortality in-hospital for patients undergoing elective catheter ablation for atrial fibrillation is low

September 4, 2026
Next Post
No difference in PET-CT surveillance versus planned neck dissection in advanced head and neck cancer

Neoadjuvant Nivolumab and Ipilimumab in Resectable Stage III Melanoma

Basic life support associated with greater survival in cardiac arrest

Early blood-pressure control not associated with improved outcomes in patients with undifferentiated stroke

No difference in mortality for intensive versus standard reduction in blood pressure in intracerebral hemorrhage: The ATACH-2 trial

Andexanet reduces hematoma expansion in factor Xa inhibitor-associated intracerebral hemorrhage

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • The rate of urethrocutaneous fistula following caudal and penile blocks for hypospadias repair may be similar
  • Adjuvant chemotherapy not linked to improved outcomes in localized appendiceal adenocarcinoma
  • Deep learning model improved cancer recurrence prediction for pediatric glioma using serial imaging
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.